SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019933
Filing Date
2018-08-07
Accepted
2018-08-07 16:13:10
Documents
61
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aveo-10q_20180630.htm 10-Q 2903212
2 EX-31.1 aveo-ex311_6.htm EX-31.1 16537
3 EX-31.2 aveo-ex312_10.htm EX-31.2 16539
4 EX-32.1 aveo-ex321_7.htm EX-32.1 4480
5 EX-32.2 aveo-ex322_9.htm EX-32.2 4477
  Complete submission text file 0001564590-18-019933.txt   12725130

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aveo-20180630.xml EX-101.INS 3414192
7 XBRL TAXONOMY EXTENSION SCHEMA aveo-20180630.xsd EX-101.SCH 65466
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20180630_cal.xml EX-101.CAL 50389
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20180630_def.xml EX-101.DEF 303216
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20180630_lab.xml EX-101.LAB 497694
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20180630_pre.xml EX-101.PRE 444152
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617- 531-2130
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 18998106
SIC: 2834 Pharmaceutical Preparations